￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
[Very Important] Precautions for lung cancer patients taking Xalkore (crizotinib)

2025-10-19 11:44:20

Check Details
Analysis of the efficacy of Erlotinib Hydrochloride Tablets in the second-line treatment of non-small cell lung cancer

2025-10-19 11:44:20

Check Details
To save money when buying medicines, refer to the 2021 medical insurance reimbursement conditions for Xalkori (crizotinib)

2025-10-19 11:44:20

Check Details
Any progress? Analysis of the effectiveness and safety of Xalkori in the treatment of ALK-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
How long does it take for nivolumab to work after the patient is injected?

2025-10-19 11:44:20

Check Details
Will nivolumab be reimbursed by medical insurance in 2021?

2025-10-19 11:44:20

Check Details
What patients with lung cancer need to know when using Erlotinib Hydrochloride Tablets (Tarceva)

2025-10-19 11:44:20

Check Details
Efficacy and safety of Erlotinib Hydrochloride Tablets in the treatment of advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Are there any tests needed before taking the targeted drug cabozantinib?

2025-10-19 11:44:20

Check Details
Will Giteri (afatinib) be included in the national medical insurance in China in 2021?

2025-10-19 11:44:20

Check Details
Is the targeted drug cabozantinib covered by medical insurance?

2025-10-19 11:44:20

Check Details
China Food and Drug Administration approves erlotinib hydrochloride tablets for third-line treatment of advanced non-small cell lung cancer after failure of previous chemotherapy

2025-10-19 11:44:20

Check Details
Category
相关知识